Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Spencer

Showing results (81-90 of 111) with videos related to

Pageof 12
Sort By:
Plos One|September 5, 2008
Mechanisms of hybrid oligomer formation in the pathogenesis of combined Alzheimer's and Parkinson's diseasesIgor F Tsigelny, Leslie Crews, Paula Desplats, et al.
Translational Neurodegeneration|June 20, 2020
Upregulation of RIN3 induces endosomal dysfunction in Alzheimer's diseaseRuinan Shen, Xiaobei Zhao, Lu He, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|October 26, 2022
An additive destabilising effect of compound T60I and V122I substitutions in ATTRv amyloidosisTatiana Prokaeva, Elena S Klimtchuk, Polina Feschenko, et al.
Molecular & Cellular Proteomics : MCP|May 14, 2008
Amyloidogenic and associated proteins in systemic amyloidosis proteome of adipose tissueFrancesca Lavatelli, David H Perlman, Brian Spencer, et al.
Journal of Neuroinflammation|December 20, 2015
Hypoestoxide reduces neuroinflammation and α-synuclein accumulation in a mouse model of Parkinson's diseaseChangyoun Kim, Emmanuel Ojo-Amaize, Brian Spencer, et al.
Molecular Neurodegeneration|August 11, 2018
Immunotherapy targeting toll-like receptor 2 alleviates neurodegeneration in models of synucleinopathy by modulating α-synuclein transmission and neuroinflammationChangyoun Kim, Brian Spencer, Edward Rockenstein, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 21, 2012
In vivo alterations in calcium buffering capacity in transgenic mouse model of synucleinopathyLidia Reznichenko, Qun Cheng, Krystal Nizar, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 11, 2014
Reducing C-terminal-truncated alpha-synuclein by immunotherapy attenuates neurodegeneration and propagation in Parkinson's disease-like modelsDora Games, Elvira Valera, Brian Spencer, et al.
ACS Chemical Biology|July 23, 2025
Neutral pH-Selective Inhibition of Cytosolic Cathepsin B: A Novel Drug Targeting Strategy for Traumatic Brain Injury and Alzheimer's DiseaseVivian Hook, Sonia Podvin, Michael C Yoon, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 6, 2019
Effects of single and combined immunotherapy approach targeting amyloid β protein and α-synuclein in a dementia with Lewy bodies-like modelMarkus Mandler, Edward Rockenstein, Cassia Overk, et al.
Pageof 12

Showing results (81-90 of 111) with videos related to

Sort By:
Pageof 12
Plos One|September 5, 2008
Mechanisms of hybrid oligomer formation in the pathogenesis of combined Alzheimer's and Parkinson's diseasesIgor F Tsigelny, Leslie Crews, Paula Desplats, et al.
Translational Neurodegeneration|June 20, 2020
Upregulation of RIN3 induces endosomal dysfunction in Alzheimer's diseaseRuinan Shen, Xiaobei Zhao, Lu He, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|October 26, 2022
An additive destabilising effect of compound T60I and V122I substitutions in ATTRv amyloidosisTatiana Prokaeva, Elena S Klimtchuk, Polina Feschenko, et al.
Molecular & Cellular Proteomics : MCP|May 14, 2008
Amyloidogenic and associated proteins in systemic amyloidosis proteome of adipose tissueFrancesca Lavatelli, David H Perlman, Brian Spencer, et al.
Journal of Neuroinflammation|December 20, 2015
Hypoestoxide reduces neuroinflammation and α-synuclein accumulation in a mouse model of Parkinson's diseaseChangyoun Kim, Emmanuel Ojo-Amaize, Brian Spencer, et al.
Molecular Neurodegeneration|August 11, 2018
Immunotherapy targeting toll-like receptor 2 alleviates neurodegeneration in models of synucleinopathy by modulating α-synuclein transmission and neuroinflammationChangyoun Kim, Brian Spencer, Edward Rockenstein, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 21, 2012
In vivo alterations in calcium buffering capacity in transgenic mouse model of synucleinopathyLidia Reznichenko, Qun Cheng, Krystal Nizar, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 11, 2014
Reducing C-terminal-truncated alpha-synuclein by immunotherapy attenuates neurodegeneration and propagation in Parkinson's disease-like modelsDora Games, Elvira Valera, Brian Spencer, et al.
ACS Chemical Biology|July 23, 2025
Neutral pH-Selective Inhibition of Cytosolic Cathepsin B: A Novel Drug Targeting Strategy for Traumatic Brain Injury and Alzheimer's DiseaseVivian Hook, Sonia Podvin, Michael C Yoon, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 6, 2019
Effects of single and combined immunotherapy approach targeting amyloid β protein and α-synuclein in a dementia with Lewy bodies-like modelMarkus Mandler, Edward Rockenstein, Cassia Overk, et al.
Pageof 12